Genoptræning Danmark ApS: Financial statements 2024
CVR: 41626798
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Genoptræning Danmark ApS (CVR 41626798) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 2,181,472 and a net result of DKK 617,783 compared with DKK 114,738 the year before. That is an increase of 34.3% compared with the year before. Equity in the 2024 report amounted to DKK -173,440. The company had 5 employees in the financial year.
- Gross Profit
- DKK 2,181,472
- Profit/Loss
- DKK 617,783
- Equity
- DKK -173,440
- Total Assets
- DKK 1,712,571
- Employees
- 5
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 2.2M | 618K | -173K | 5 |
| 2023 | - | 1.6M | 115K | -1.5M | 3 |
| 2022 | - | 503K | -365K | -1.6M | 2 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
As of September 1, 2024, Back To Life Holding ApS is registered as an owner of Genoptræning Danmark ApS with an ownership share of 90%.
Genoptræning Danmark ApS has published its annual report for 2023. Gross profit came to DKK 1,624,134, and the net result was DKK 114,738.
About Genoptræning Danmark ApS
Genoptræning Danmark ApS is a Danish company of the type Anpartsselskab based in Aalborg SV, founded in 2020. The company is registered under the industry Andre sociale støtte- og rådgivningsaktiviteter uden institutionsophold. The management consists of Mikkel Salling Holmgaard. The company is owned by Back To Life Holding ApS. The company has 4 employees (2026). In 2025, the company reported a gross profit of DKK 1,686,355 and a net result of DKK -266,841 compared with DKK 617,783 the year before. Equity in the 2025 report amounted to DKK 109,719.